Literature DB >> 30187813

Signaling by discoidin domain receptor 1 in cancer metastasis.

Mayur Gadiya1,2, Goutam Chakraborty3.   

Abstract

Collagen is the most abundant component of tumor extracellular matrix (ECM). ECM collagens are known to directly interact with the tumor cells via cell surface receptor and play crucial role in tumor cell survival and promote tumor progression. Collagen receptor DDR1 is a member of receptor tyrosine kinase (RTK) family with a unique motif in the extracellular domain resembling Dictyostelium discoideum protein discoidin-I. DDR1 displays delayed and sustained activation upon interaction with collagen and recent findings have demonstrated that DDR1-collagen signaling play important role in cancer progression. In this review, we discuss the current knowledge on the role of DDR1 in cancer metastasis and possibility of a potential therapeutic approach of DDR1 targeted therapy in cancer.

Entities:  

Keywords:  Cell Signaling; DDR1; Dormancy; Metastasis; TM4SF1

Mesh:

Substances:

Year:  2018        PMID: 30187813      PMCID: PMC6363035          DOI: 10.1080/19336918.2018.1520556

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  91 in total

1.  Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons.

Authors:  R S Bhatt; T Tomoda; Y Fang; M E Hatten
Journal:  Genes Dev       Date:  2000-09-01       Impact factor: 11.361

2.  The D2 period of collagen II contains a specific binding site for the human discoidin domain receptor, DDR2.

Authors:  Birgit Leitinger; Andrzej Steplewski; Andrzej Fertala
Journal:  J Mol Biol       Date:  2004-12-03       Impact factor: 5.469

Review 3.  Mechanisms governing metastatic dormancy and reactivation.

Authors:  Filippo G Giancotti
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

Review 4.  Fibrillar Collagens.

Authors:  Jordi Bella; David J S Hulmes
Journal:  Subcell Biochem       Date:  2017

5.  Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation.

Authors:  Sanjeev Das; Pat P Ongusaha; Yoon Sun Yang; Jin-Mo Park; Stuart A Aaronson; Sam W Lee
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

6.  Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.

Authors:  Daniel L Abravanel; George K Belka; Tien-chi Pan; Dhruv K Pant; Meredith A Collins; Christopher J Sterner; Lewis A Chodosh
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

7.  Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis.

Authors:  Nicola Ferri; Neil O Carragher; Elaine W Raines
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 8.  Receptor tyrosine kinases: legacy of the first two decades.

Authors:  Joseph Schlessinger
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-03-01       Impact factor: 10.005

9.  Structure of the discoidin domain receptor 1 extracellular region bound to an inhibitory Fab fragment reveals features important for signaling.

Authors:  Federico Carafoli; Marie Cathrin Mayer; Kazushige Shiraishi; Mira Anguelova Pecheva; Lai Yi Chan; Ruodan Nan; Birgit Leitinger; Erhard Hohenester
Journal:  Structure       Date:  2012-04-03       Impact factor: 5.006

Review 10.  Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.

Authors:  Ramesh Butti; Sumit Das; Vinoth Prasanna Gunasekaran; Amit Singh Yadav; Dhiraj Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more
  17 in total

Review 1.  Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models.

Authors:  Ulrich H Weidle; Adam Nopora
Journal:  Cancer Genomics Proteomics       Date:  2020 Jul-Aug       Impact factor: 4.069

Review 2.  Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance.

Authors:  Behrad Darvishi; Mohammad Reza Eisavand; Keivan Majidzadeh-A; Leila Farahmand
Journal:  Br J Cancer       Date:  2022-02-05       Impact factor: 9.075

Review 3.  Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics.

Authors:  Bikashita Kalita; Mohane Selvaraj Coumar
Journal:  Cell Oncol (Dordr)       Date:  2021-04-29       Impact factor: 6.730

Review 4.  Glycosylation and raft endocytosis in cancer.

Authors:  Ludger Johannes; Anne Billet
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

Review 5.  Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy.

Authors:  Marilina García-Aranda; Maximino Redondo
Journal:  Int J Mol Sci       Date:  2019-05-09       Impact factor: 5.923

6.  Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.

Authors:  Yiran Tao; Ruixue Wang; Qinhuai Lai; Mengdan Wu; Yuxi Wang; Xiaohua Jiang; Lishi Zeng; Shijie Zhou; Zhongping Li; Tinghan Yang; Yuqin Yao; Yangping Wu; Lin Yu; Yuyin Fu; Weirong Lai; Yujia Peng; Ying Lu; Zhixiong Zhang; Cuiyu Guo; Guangbing Zhang; Lantu Gou; Jinliang Yang
Journal:  Mol Oncol       Date:  2019-07-22       Impact factor: 6.603

7.  Insight into Cisplatin-Resistance Signaling of W1 Ovarian Cancer Cells Emerges mTOR and HSP27 as Targets for Sensitization Strategies.

Authors:  Kathleen Wantoch von Rekowski; Philipp König; Svenja Henze; Martin Schlesinger; Piotr Zawierucha; Radosław Januchowski; Gerd Bendas
Journal:  Int J Mol Sci       Date:  2020-12-03       Impact factor: 5.923

8.  Functional annotation of lung cancer‒associated genetic variants by cell type‒specific epigenome and long-range chromatin interactome.

Authors:  Andrew J Lee; Inkyung Jung
Journal:  Genomics Inform       Date:  2021-03-25

9.  Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations.

Authors:  Maryam Shariati; Kurt W Evans; Xiaofeng Zheng; Christopher A Bristow; Patrick Kwok-Shing Ng; Yasmeen Q Rizvi; Coya Tapia; Fei Yang; Alessandro Carugo; Timothy P Heffernan; Michael D Peoples; Debu Tripathy; Funda Meric-Bernstam
Journal:  Oncogene       Date:  2021-06-09       Impact factor: 9.867

10.  Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts.

Authors:  Benjamin Wasinski; Anjum Sohail; R Daniel Bonfil; Seongho Kim; Allen Saliganan; Lisa Polin; Mohamad Bouhamdan; Hyeong-Reh C Kim; Marco Prunotto; Rafael Fridman
Journal:  Sci Rep       Date:  2020-02-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.